Last $61.45 USD
Change Today -1.11 / -1.77%
Volume 8.9M
MRK On Other Exchanges
New York
EN Paris
Sao Paulo
As of 8:04 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

One Merck Drive

PO Box 100

Whitehouse Station, NJ 08889

United States

Phone: 908-423-1000


Merck & Co., Inc., a health care company, offers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company’s operations are principally managed on a products basis and comprise four segments, which are as follows: Pharmaceutical, Animal Health, Consumer Care, and Alliances (which includes the company’s relationship with AstraZeneca LP). Product Sales Sales of the company’s pharmaceutical products, as well as sales of animal health and consumer care products, are as follows: Pharmaceutical The company’s pharmaceutical products include therapeutic and preventive agents, sold by prescription, for the treatment of human disorders. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The company sells these human health vaccines primarily to physicians, wholesalers, physician distributors and government entities. The company also has animal health operations that discover, develop, manufactures and markets animal health products, including vaccines, which the company sells to veterinarians, distributors and animal producers. Additionally, the company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products, which are sold through wholesale and retail drug, food chain and mass merchandiser outlets, as well as club stores and specialty channels. Certain of the products within the company’s franchises are as follows: Primary Care and Women’s Health Cardiovascular: Zetia (ezetimibe) (marketed as Ezetrol outside the United States); and Vytorin (ezetimibe/simvastatin) (marketed as Inegy outside the United States), cholesterol modifying medicines. Diabetes and Obesity: Januvia (sitagliptin) and Janumet (sitagliptin/metformin HCl) for the treatment of type 2 diabetes. Respiratory: Nasonex (mometasone furoate monohydrate), an inhaled nasal corticosteroid for the treatment of nasal allergy symptoms; Singulair (montelukast), a medicine indicated for the chronic treatment of asthma and the relief of symptoms of allergic rhinitis; Dulera Inhalation Aerosol (mometasone furoate/formoterol fumarate dihydrate), a combination medicine for the treatment of asthma; and Asmanex Twisthaler (mometasone furoate inhalation powder), an inhaled corticosteroid for first-line maintenance treatment of asthma in patients four years of age and older. Women’s Health and Endocrine: NuvaRing (etonogestrel/ethinyl estradiol vaginal ring), a vaginal contraceptive ring; Fosamax (alendronate sodium) for the treatment and prevention of osteoporosis; Follistim AQ (follitropin beta injection), a fertility treatment; Implanon (etonogestrel implant), a single-rod subdermal contraceptive implant; and Cerazette (desogestrel), a progestin only oral contraceptive. Other: Arcoxia (etoricoxib) for the treatment of arthritis and pain, which the company markets outside the United States; and Avelox (moxifloxacin), a broad-spectrum fluoroquinolone antibiotic for the treatment of certain respiratory and skin infections, which the company only markets in the United States. Hospital and Specialty Immunology: Remicade (infliximab) and Simponi (golimumab) for the treatment of inflammatory diseases, which the company markets in Europe, Russia and Turkey. Infectious Disease: Isentress (raltegravir), an antiretroviral therapy for use in combination therapy for the treatment of HIV-1 infection; Cancidas (caspofungin acetate), an anti-fungal product; PegIntron (peginterferon alpha-2b)


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $61.45 USD -1.11

MRK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €128.50 EUR +1.02
Gilead Sciences Inc $102.45 USD -2.58
GlaxoSmithKline PLC 1,496 GBp -1.00
Roche Holding AG SFr.253.10 CHF +1.40
Sanofi €82.23 EUR +0.24
View Industry Companies

Industry Analysis


Industry Average

Valuation MRK Industry Range
Price/Earnings 34.2x
Price/Sales 4.2x
Price/Book 4.0x
Price/Cash Flow 33.1x
TEV/Sales 3.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at